“TED is 5 times more prevalent in women, and because of that, men are often overlooked for the diagnosis,” Nijm said. The ...

Secukinumab does not show greater clinical efficacy than placebo in patients with moderate-to-severe Graves' orbitopathy, ...

Vyvgart, an FcRn inhibitor already approved for generalized myasthenia gravis, is also being tested in myositis, Sjögren’s disease and the “clinically related” Graves disease.

Maggie Smith would have been 91 on Sunday, Dec. 28 and fans all over the globe are paying tribute to the iconic actress, one ...

Environmental exposures are emerging as major contributors to autoimmune risk: Studies link air pollution, PFAS, and ...

Argenx discontinues its Phase 3 UplighTED trial in thyroid eye disease after an interim futility review, while analysts ...

Two phase 3 trials evaluating a subcutaneous (SC) formulation of efgartigimod (efgartigimod alfa and hyaluronidase-qvfc ), a neonatal Fc receptor blocker, ...

Shanghai Scizeng Medical Technology Co., LTD, a subsidiary of Changchun GeneScience Pharmaceutical Co., Ltd. ("GenSci"), RTW Investments, LP ("RTW"), and Yarrow Bioscience, Inc. ("Yarrow") today ...

BHVN’s investment case definitely weakened after Opakalim’s Phase 2 MDD miss. This also means they’ll discontinue their ...

A deadly plague swept through Pharaoh Akhenaten's holy city, killing hundreds—but he refused to help. Now, mass graves of ...

AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...

Archaeologists find four mass graves along a Czech highway, revealing soldiers from two wars fought 121 years apart.